RxDoctor Payments Data

Alexandra Jones, DO

Family Medicine · Olathe, KSNPI 1689203200

Payments from drug & device makers

$872in general payments, 2019–2025

Across 36 payments — averaging $24.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kerecis Limited$174
  • Shield Therapeutics Inc$143
  • Novo Nordisk$131
  • Lilly USA, LLC$88
  • AstraZeneca$82
  • Otsuka America Pharmaceutical, Inc.$78
  • plus $177 from 5 others

What the payments were for

  • Food & beverage$872100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$872 in reported general payments places this provider in the 60th percentile of 1,469 family medicine providers in Kansas.

See all family medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$27,476
Medicare patients
122
Services billed
564

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban20$18,281
JardianceEmpagliflozin15$11,119
SynthroidLevothyroxine Sodium28$2,319
Lantus SolostarInsulin Glargine,hum.Rec.Anlog11$2,163
Atorvastatin Calcium128$1,022
Omeprazole65$981
Pravastatin Sodium85$849
Levothyroxine Sodium122$822
Ezetimibe15$716
Losartan Potassium71$706
Pantoprazole Sodium85$656
Bupropion XlBupropion Hcl24$594
Baclofen19$590
Rosuvastatin Calcium52$580
Lisinopril66$556

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$48$18,28120 claims
AbbVieSynthroid$54$2,31928 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,469 family medicine providers in Kansas.

Other family medicine in Olathe

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →